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Pseudoangiomatous stromal hyperplasia (PASH) of the breast is a benign lesion, charac-
terized by a dense proliferation of stromal mesenchymal cells of myofibroblastic origin
forming empty, slit-like channels. We report PASH in a 12-year-old girl with a huge rapidly
enlarged right breast. Biopsy of the mass showed histopathologic features characteristic of
PASH. Immunohistochemical studies revealed diffuse positive membranous immunore-
activity to CD34. Although it is a benign lesion, lumpectomy was performed to minimize
the damage from developing breast tissue.
Copyright © 2015, the Authors. Published by Elsevier Inc. under copyright license from the
University of Washington. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Pseudoangiomatous stromal hyperplasia (PASH) is an un-
usual benign breast condition that was first described in
1986 [1]. The reported age range of patients is 14-67 years,
although the vast majority of PASH patients present in
their late thirties and forties [2]. It is histologically defined
as a complex network of slit-like spaces lined by
endothelial-like spindle cells against a background of
stromal hyperplasia [3]. On histologic analysis, PASH can be
mistaken for a low-grade angiosarcoma and phyllodes
tumor, but it is a benign condition. Correct identification of
PASH of the breast has important treatment implications
for patients [3-5].s.
om (E. Almohawes).
blished by Elsevier Inc. u
ND license (http://creativCase report
A 12-year-old girl, complaining of an enlargement of her right
breast, presented for diagnostic work-up. She mentioned that
2 months ago she had palpated a small nodule near the
nipple, which thereafter rapidly increased in size. There was
no nipple discharge. She had an unremarkable personal and
family history, with reported menarche at 11 years and a
normal menstrual cycle.
Physical examination revealed an overall enlarged right
breast replaced with a huge lump occupying the whole breast,
with diffuse tenderness and firmness on palpation. There was
no evidence of thickening of the breast skin or nipple retrac-
tion. (Fig. 1).nder copyright license from the University of Washington. This is
ecommons.org/licenses/by-nc-nd/4.0/).
Fig 1 e Image showing the asymmetry and the large mass
in the right breast on presentation.
R a d i o l o g y C a s e R e p o r t s 1 0 ( 2 0 1 5 ) 1e42The patient was initially examined with breast ultraso-
nography, with a high frequency (8-10 MHz) linear array head,
which showed a huge right breast heterogeneous hypoechoicFig 2 e Ultrasonography showed a huge right breast with well-d
at maximum diameter, with cystic channels noted within the m
imaging.mass measuring 17.3 cm at maximum diameter with cystic
channels noted within themass. The ipsilateral axilla showed
benign-looking lymph nodes (Fig. 2).
The differential diagnosis at this point included low-grade
angiosarcoma, PASH, and phyllodes. Therefore, sampling was
advised by the Breast Imaging-Reporting and Data System
(BIRADS 4).
Under ultrasonography guidance, core needle biopsy was
performed, which showed the presence of spindle cells in
the fibrous tissue in a pseudoangiomatous pattern, fitting
the diagnosis of PASH. A complex pattern of anastomosing
slit-like spaces in a dense collagenous stroma was seen.
These spaces are lined with myofibroblasts rather than
endothelial cells and do not contain red blood cells. This was
the same finding on the final histopathology after excision
(Fig. 3-5).
Immunohistochemical studies revealed diffuse positive
membranous immunoreactivity to CD34. In addition, negative
staining was observed for CD31, a cellular adhesion marker
highly restricted to endothelial neoplasms, and for desmin, a
marker for cytoplasmic intermediate filaments found in the
smooth muscle. The results of this panel of studies confirmed
the characteristic immunophenotype of PASH while helping
exclude lesions of vascular endothelial and smooth muscle
origin such as angiosarcoma.
The patient was finally operated; lumpectomy with
reduction mammoplasty was performed. The patient had
excellent cosmetic results postoperatively. The patient has
been followed up for 6 months now without evidence of
recurrence (Fig. 6).efined heterogeneous hypoechoic mass measuring 17.3 cm
ass and no significant vascularity detected on Doppler
Fig 3 e Pseudoangiomatous stromal hyperplasia. A
photomicrograph showing a cellular stromal lesion
between the bland breast ducts (hematoxylin and eosin,
magnification £100).
Fig 5 e Pseudoangiomatous stromal hyperplasia. A
photomicrograph showing the myofibroblast cells lining
the vascular-like (pseudoangiomatous) spaces. The
myofibroblast cells are spindle attenuated with bland
spindle nuclei (hematoxylin and eosin,magnification£400).
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PASH is a benign proliferation of themammary stromal tissue.
On histologic analysis, it shows complex interanastomosing
slit-like spaces which appear to be lined by spindle cells in the
breast parenchyma [1].
We present a case of a huge, rapidly growing PASH in a
12-year-old patient, which is not frequently seen at this age
group; to our knowledge, the youngest female patient reported
in literature with PASH is a 10-year-old girl [6].This tumor
mimicked a low-grade angiosarcoma on ultrasonography; true
cut biopsy revealed PASH, and surgical excisionwasperformed.
It is important to differentiate the lesion from angio-
sarcoma. It can be confused histologically with PASH.Fig 4 e Pseudoangiomatous stromal hyperplasia. A
photomicrograph showing the anastomosing vascular-like
(pseudoangiomatous) channels expanding the interlobular
stroma (hematoxylin and eosin, magnification £100).Angiosarcoma often shows a more aggressive infiltrative
pattern into surrounding fibroadipose breast tissue and is
highly vascular, lined by endothelial cells. It does not show a
collagenous stroma. Angiosarcoma displays positive immuno-
reactivity for CD31 and, although less frequently and with less
sensitivity, for the factor VIIIerelated or von Willebrand factor
antigens [7].
PASH is associated with several benign entities including
proliferative and nonproliferative fibrocystic changes, such
as fibroadenomas, gynecomastia, normal breast tissue, and
sclerosing lobular hyperplasias. The etiology and pathogen-
esis remain unknown.
Hormonal factors are thought to play a role in the etiology
of PASH [8].
Microscopically, PASH consists of a network of slit-like
spaces lined by myofibroblasts that resemble vascular
spaces. On immunohistochemistry, PASH is positive for CD34
and vimentin and negative for factor VIIIerelated antigen and
cytokeratins [9,10].
On radiologic examination, there are no specific or diag-
nostic features. Most of these tumorsmimic fibroadenomas or
hamartomas and angiosarcomas, and larger tumors can be
mistaken for phyllodes [9,11,12].
Management with wide local excision is the treatment of
choice for PASH owing to its uncertain natural history [13].
The recurrence rates of PASH after excision are reported to
range from 15% to 22% although longer follow-up studies are
needed to evaluate the recurrence rate. The reason for
recurrence could be attributed to the growth of a residual
mass after incomplete excision [14,15].Conclusion
PASH is a benign entity that is regarded as a myofibroblastic
proliferation of the breast.
Fig 6 e Postsurgical excision specimen. Postoperative pictures show good cosmetic results with slight asymmetry between
both sides.
R a d i o l o g y C a s e R e p o r t s 1 0 ( 2 0 1 5 ) 1e44In summary, we present the case of a huge and rapidly
growing PASH in a 12-year-old patient, which is an uncom-
monly seen lesion in this age group and is infrequently
reported. The lesion reported is one of the largest in the
literature and the largest in a teenage girl.
Local excision is curative in most cases. Although recur-
rence may occur, the overall rate is low. Follow-up after
excision is recommended as local recurrence has been
reported.r e f e r e n c e s
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